In the present study, flow cytometry data showed that treatment of pancreatic cancer cells with pristimerin resulted in signifiant induction of apoptosis, which was further verified by cleavage of caspase-3, fluorescence microscopy and caspase-3 activity. The gene discussed is CASP3; the disease is pancreatic neoplasm.